SPRY insider transactions
ARS Pharmaceuticals Inc. (SPRY) Form 4 insider transactions - real-time wire coverage of every officer, director, and 10% owner trade.
SPRY insiders
Everyone who has filed a Form 3, 4, 5 or 144 at ARS Pharmaceuticals Inc., latest first. Follow anyone to get their next filing.
- John L SlebirChief Legal Officer, since October 2026
- Richard E LowenthalPresident and CEO, Director, 10% owner, since November 2022-$23.8M
- Margaret Ekins SmithChief Commercial Officer, since August 2026
- Donn CasalePresident, since June 2026
- Ra Capital Management, L.P.Director, 10% owner, since November 2022+$44.7M
- Rajeev DadooDirector, since November 2022
- Michael KellyDirector, since November 2022
- Pratik ShahDirector, since November 2022
- Laura ShawverDirector-$8.63M
- Saqib IslamDirector
- Phillip M SchneiderDirector, since November 2022
- Brent L SaundersDirector, since November 2022-$1.71M
- Peter A. ThompsonDirector+$3.1M-$12.6M
- Eric KarasChief Commercial Officer, since November 2022-$1.31M
- Alexander A FitzpatrickChief Legal Officer, since December 2022+$320K-$1.49M
- Kathleen D. ScottChief Financial Officer, since November 2022+$51.5K-$1.29M
- Brian DorseyChief Operating Officer, since December 2022-$1.82M
- Justin ChakmaChief Business Officer, since November 2022-$8.56M
- Sarina TanimotoChief Medical Officer, 10% owner, since November 2022-$23.8M
- James E Flynn10% owner, since November 2022-$23.8M
- Orbimed Advisors LLCDirector+$3.1M-$12.6M
- The Biotech Growth Trust PLCInsider
- Jonathan S LeffDirector, since November 2022
- Jeffrey C. PepeOfficer, since September 2022
- Jonathan D RootDirector+$36K
- Powell Andrew Kenneth WilliamDirector
- Maria KoehlerDirector, since March 2021
- Robert HershbergDirector
- Vickie L CappsDirector
- Jonathan PiazzaOfficer
- Valerie OdegardOfficer
- Naomi HunderOfficer
- Russ HawkinsonOfficer+$4,200
Recent Form 3, 4, and 5 filings for SPRY
- Chief Legal Officer Slebir John L was granted 1,199,482 stock options (SEC Form 4)4 - ARS Pharmaceuticals, Inc. (0001671858) (Issuer)
- SEC Form 3 filed by new insider Slebir John L3 - ARS Pharmaceuticals, Inc. (0001671858) (Issuer)
- SEC Form 4 filed by ARS Pharmaceuticals Inc.4 - ARS Pharmaceuticals, Inc. (0001671858) (Issuer)
- SEC Form 4 filed by Chief Commercial Officer Smith Margaret Ekins4 - ARS Pharmaceuticals, Inc. (0001671858) (Issuer)
- SEC Form 3 filed by new insider Smith Margaret Ekins3 - ARS Pharmaceuticals, Inc. (0001671858) (Issuer)
- SEC Form 4 filed by President Casale Donn4 - ARS Pharmaceuticals, Inc. (0001671858) (Issuer)
- SEC Form 4 filed by Director Ra Capital Management, L.P.4 - ARS Pharmaceuticals, Inc. (0001671858) (Issuer)
- SEC Form 4 filed by Director Dadoo Rajeev4 - ARS Pharmaceuticals, Inc. (0001671858) (Issuer)
- SEC Form 4 filed by Director Shah Pratik4 - ARS Pharmaceuticals, Inc. (0001671858) (Issuer)
- SEC Form 4 filed by Director Kelly Michael4 - ARS Pharmaceuticals, Inc. (0001671858) (Issuer)
- SEC Form 4 filed by Director Schneider Phillip M4 - ARS Pharmaceuticals, Inc. (0001671858) (Issuer)
- SEC Form 4 filed by Director Thompson Peter A.4 - ARS Pharmaceuticals, Inc. (0001671858) (Issuer)
- SEC Form 4 filed by Director Islam Saqib4 - ARS Pharmaceuticals, Inc. (0001671858) (Issuer)
- SEC Form 4 filed by Director Shawver Laura4 - ARS Pharmaceuticals, Inc. (0001671858) (Issuer)
- SEC Form 4 filed by Director Saunders Brent L4 - ARS Pharmaceuticals, Inc. (0001671858) (Issuer)
- Chief Commercial Officer Karas Eric exercised 25,000 shares at a strike of $1.50 and sold $250,000 worth of shares (25,000 units at $10.00) as part of a pre-agreed trading plan (SEC Form 4)4 - ARS Pharmaceuticals, Inc. (0001671858) (Issuer)
- Chief Legal Officer Fitzpatrick Alexander A sold $33,550 worth of shares (3,355 units at $10.00) as part of a pre-agreed trading plan, decreasing direct ownership by 4% to 90,910 units (SEC Form 4)4 - ARS Pharmaceuticals, Inc. (0001671858) (Issuer)
- SEC Form 3 filed by new insider Casale Donn3 - ARS Pharmaceuticals, Inc. (0001671858) (Issuer)
- SEC Form 4 filed by Chief Financial Officer Scott Kathleen D.4 - ARS Pharmaceuticals, Inc. (0001671858) (Issuer)
- SEC Form 4 filed by Chief Commercial Officer Karas Eric4 - ARS Pharmaceuticals, Inc. (0001671858) (Issuer)
- SEC Form 4 filed by Chief Legal Officer Fitzpatrick Alexander A4 - ARS Pharmaceuticals, Inc. (0001671858) (Issuer)
- SEC Form 4 filed by Chief Operating Officer Dorsey Brian4 - ARS Pharmaceuticals, Inc. (0001671858) (Issuer)
- SEC Form 4 filed by Chief Business Officer Chakma Justin4 - ARS Pharmaceuticals, Inc. (0001671858) (Issuer)
- SEC Form 4 filed by CHIEF MEDICAL OFFICER Tanimoto Sarina4 - ARS Pharmaceuticals, Inc. (0001671858) (Issuer)
- SEC Form 4 filed by PRESIDENT AND CEO Lowenthal Richard E4 - ARS Pharmaceuticals, Inc. (0001671858) (Issuer)
- Chief Operating Officer Dorsey Brian exercised 21,828 shares at a strike of $0.64 and sold $190,050 worth of shares (21,828 units at $8.71) (SEC Form 4)4 - ARS Pharmaceuticals, Inc. (0001671858) (Issuer)
- Chief Business Officer Chakma Justin exercised 30,000 shares at a strike of $0.84 and sold $1,476,147 worth of shares (166,380 units at $8.87), closing all direct ownership in the company (SEC Form 4)4 - ARS Pharmaceuticals, Inc. (0001671858) (Issuer)
- Director Shah Pratik gifted 350,000 shares (SEC Form 4)4 - ARS Pharmaceuticals, Inc. (0001671858) (Issuer)
- PRESIDENT AND CEO Lowenthal Richard E sold $724,345 worth of shares (50,000 units at $14.49) (SEC Form 4)4 - ARS Pharmaceuticals, Inc. (0001671858) (Issuer)
- Chief Financial Officer Scott Kathleen D. exercised 12,500 shares at a strike of $1.50 and sold $187,500 worth of shares (12,500 units at $15.00) (SEC Form 4)4 - ARS Pharmaceuticals, Inc. (0001671858) (Issuer)
- CHIEF MEDICAL OFFICER Tanimoto Sarina sold $703,755 worth of shares (50,000 units at $14.08) (SEC Form 4)4 - ARS Pharmaceuticals, Inc. (0001671858) (Issuer)
- Chief Commercial Officer Karas Eric exercised 15,000 shares at a strike of $1.50 and sold $254,860 worth of shares (15,000 units at $16.99) (SEC Form 4)4 - ARS Pharmaceuticals, Inc. (0001671858) (Issuer)
- Large owner Flynn James E sold $13,663,151 worth of shares (740,149 units at $18.46) (SEC Form 4)4 - ARS Pharmaceuticals, Inc. (0001671858) (Issuer)
- SEC Form 4 filed by Director Ra Capital Management, L.P.4 - ARS Pharmaceuticals, Inc. (0001671858) (Issuer)
- SEC Form 4 filed by Director Dadoo Rajeev4 - ARS Pharmaceuticals, Inc. (0001671858) (Issuer)
- SEC Form 4 filed by Director Thompson Peter A.4 - ARS Pharmaceuticals, Inc. (0001671858) (Issuer)
- SEC Form 4 filed by Director Shah Pratik4 - ARS Pharmaceuticals, Inc. (0001671858) (Issuer)
- SEC Form 4 filed by Director Kelly Michael4 - ARS Pharmaceuticals, Inc. (0001671858) (Issuer)
- SEC Form 4 filed by Director Islam Saqib4 - ARS Pharmaceuticals, Inc. (0001671858) (Issuer)
- SEC Form 4 filed by Director Saunders Brent L4 - ARS Pharmaceuticals, Inc. (0001671858) (Issuer)
- SEC Form 4 filed by Director Schneider Phillip M4 - ARS Pharmaceuticals, Inc. (0001671858) (Issuer)
- SEC Form 4 filed by Director Shawver Laura4 - ARS Pharmaceuticals, Inc. (0001671858) (Issuer)
- Chief Commercial Officer Karas Eric exercised 15,000 shares at a strike of $1.50 and sold $240,000 worth of shares (15,000 units at $16.00) (SEC Form 4)4 - ARS Pharmaceuticals, Inc. (0001671858) (Issuer)
- Chief Financial Officer Scott Kathleen D. exercised 50,000 shares at a strike of $1.50 and sold $705,165 worth of shares (50,000 units at $14.10) (SEC Form 4)4 - ARS Pharmaceuticals, Inc. (0001671858) (Issuer)
- Director Saunders Brent L sold $1,710,024 worth of shares (120,000 units at $14.25) and exercised 120,000 shares at a strike of $1.01 (SEC Form 4)4 - ARS Pharmaceuticals, Inc. (0001671858) (Issuer)
- Chief Legal Officer Fitzpatrick Alexander A exercised 100,000 shares at a strike of $5.58 and sold $1,451,513 worth of shares (102,969 units at $14.10), decreasing direct ownership by 3% to 89,613 units (SEC Form 4)4 - ARS Pharmaceuticals, Inc. (0001671858) (Issuer)
- Director Shawver Laura exercised 50,002 shares at a strike of $4.85 and sold $615,075 worth of shares (50,002 units at $12.30) (SEC Form 4)4 - ARS Pharmaceuticals, Inc. (0001671858) (Issuer)
- Chief Commercial Officer Karas Eric exercised 10,000 shares at a strike of $1.50 and sold $140,000 worth of shares (10,000 units at $14.00) (SEC Form 4)4 - ARS Pharmaceuticals, Inc. (0001671858) (Issuer)
- Director Shawver Laura exercised 50,000 shares at a strike of $4.85 and sold $560,446 worth of shares (50,000 units at $11.21) (SEC Form 4)4 - ARS Pharmaceuticals, Inc. (0001671858) (Issuer)
- Director Shawver Laura exercised 50,000 shares at a strike of $4.54 and sold $615,565 worth of shares (50,000 units at $12.31) (SEC Form 4)4 - ARS Pharmaceuticals, Inc. (0001671858) (Issuer)
- Director Shawver Laura exercised 50,000 shares at a strike of $3.15 and sold $555,065 worth of shares (50,000 units at $11.10) (SEC Form 4)4 - ARS Pharmaceuticals, Inc. (0001671858) (Issuer)
- SEC Form 4 filed by CHIEF MEDICAL OFFICER Tanimoto Sarina4 - ARS Pharmaceuticals, Inc. (0001671858) (Issuer)
- SEC Form 4 filed by Chief Business Officer Chakma Justin4 - ARS Pharmaceuticals, Inc. (0001671858) (Issuer)
- SEC Form 4 filed by Chief Commercial Officer Karas Eric4 - ARS Pharmaceuticals, Inc. (0001671858) (Issuer)
- SEC Form 4 filed by Chief Legal Officer Fitzpatrick Alexander A4 - ARS Pharmaceuticals, Inc. (0001671858) (Issuer)
- SEC Form 4 filed by Chief Operating Officer Dorsey Brian4 - ARS Pharmaceuticals, Inc. (0001671858) (Issuer)
- SEC Form 4 filed by PRESIDENT AND CEO Lowenthal Richard E4 - ARS Pharmaceuticals, Inc. (0001671858) (Issuer)
- SEC Form 4 filed by Chief Financial Officer Scott Kathleen D.4 - ARS Pharmaceuticals, Inc. (0001671858) (Issuer)
- CHIEF MEDICAL OFFICER Tanimoto Sarina sold $1,167,100 worth of shares (100,000 units at $11.67) (SEC Form 4)4 - ARS Pharmaceuticals, Inc. (0001671858) (Issuer)
- PRESIDENT AND CEO Lowenthal Richard E sold $1,167,100 worth of shares (100,000 units at $11.67) (SEC Form 4)4 - ARS Pharmaceuticals, Inc. (0001671858) (Issuer)